Widespread use of PSA screening has led to increased diagnosis of localized prostate cancer, making discussions around treatment important. This presentation discusses ProtecT trials and the outcomes associated with treatment successes as well as the comparison of patient reported outcomes with each treatment group. Patient reported outcomes include urinary, bowel, and sexual dysfunction as well as quality of life, anxiety, depression, and overall health evaluation.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/11/22.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to discuss the ProtecT trials and the outcomes associated with treatment successes as well as the comparison of patient reported outcomes with each treatment group.
Positives and negatives of both Uroflow and Urocuff flow measures are discussed in this presentation.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/11/22.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Mikel Gray, PhD, FNP, PNP, CUNP, CCCN, FAANP, FAAN
Consultant – Laborie Medical Technologies
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to discuss the positive and negative implications of using Uroflow or Urocuff flow measures.